Atlas Trials

Evaluation the Pharmacokinetics, Safety, Tolerability of BCD-021 in Patients With Neovascular Age-related Macular Degeneration

Clinical trial NCT02450981 · WITHDRAWN

Trial details

NCT number
NCT02450981
Sponsor
Biocad
Status
WITHDRAWN
Phase
Phase 1
Study type
INTERVENTIONAL
Neovascular Age-related Macular Degeneration
Primary completion
2016-03-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.